Literature DB >> 30153670

TGFβ Is Specifically Upregulated on Circulating CD14++ CD16+ and CD14+ CD16++ Monocytes in Patients with Atrial Fibrillation and Severe Atrial Fibrosis.

David Heinzmann, Stefan Fuß, Saskia V Ungern-Sternberg, Jürgen Schreieck, Meinrad Gawaz, Michael Gramlich, Peter Seizer.   

Abstract

BACKGROUND/AIMS: Fibrotic remodeling of the atria plays a key role in the pathogenesis of atrial fibrillation (AF). As little is known about the contribution of circulating monocytes in atrial remodeling and the pathophysiology of AF, we investigated profibrotic factors in different subsets of circulating monocytes obtained from patients with atrial fibrillation undergoing catheter ablation.
METHODS: A 3D high density voltage mapping was performed in sinus rhythm to evaluate the extent of low-voltage areas (LVAs) in the atria of 71 patients with persistent AF. Low-voltage was defined as signals of < 0.5mV during sinus rhythm. Prior to ablation, blood was drawn and monocytes were analyzed by FACS. Based on the expression of CD14 and CD16, three subgroups including CD14++ CD16- ('classical'), CD14++ CD16+ ('intermediate'), and CD14+ CD16++ ('non-classical') were analyzed for the expression of TGFb, CD147, and MMP-9, representing pivotal profibrotic pathways in myocardial remodeling.
RESULTS: Expression of TGFb was increased in CD14+ monocytes of patients with extensive LVAs compared to patients with a low extend of LVAs. While CD14++ CD16- monocytes showed no difference, CD14++ CD16+ and CD14+ CD16++ monocytes showed a strong increase of TGFb abundance. Although CD147 and MMP-9 are strongly associated with myocardial fibrosis, we found no difference in expression between the two groups in any monocyte subsets.
CONCLUSION: TGFb is specifically upregulated on CD14++ CD16+ and CD14+ CD16++ monocytes in patients with extensive LVAs undergoing catheter ablation.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Atrial Fibrosis; Atrial fibrillation; EMMPRIN; Matrix metalloproteinases; Monocyte subsets; ablation

Mesh:

Substances:

Year:  2018        PMID: 30153670     DOI: 10.1159/000492873

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Mesh induced fibrosis: The protective role of T regulatory cells.

Authors:  Amanda M Artsen; Matthew Rytel; Rui Liang; Gabrielle E King; Leslie Meyn; Steven D Abramowitch; Pamela A Moalli
Journal:  Acta Biomater       Date:  2019-07-19       Impact factor: 8.947

Review 2.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

3.  Anti-fibrotic mechanism of SPP1 knockdown in atrial fibrosis associates with inhibited mitochondrial DNA damage and TGF-β/SREBP2/PCSK9 signaling.

Authors:  Xianfeng Du; Ting Liu; Caijie Shen; Bin He; Mingjun Feng; Jing Liu; Weidong Zhuo; Guohua Fu; Binhao Wang; Yanyan Xu; Huimin Chu
Journal:  Cell Death Discov       Date:  2022-05-04

4.  MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.

Authors:  Meixia Zhang; Hechuan Wang; Xiaowen Wang; Mengjun Bie; Kai Lu; Hua Xiao
Journal:  Cell Cycle       Date:  2020-10-01       Impact factor: 4.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.